Arkadios Wealth Advisors Fulgent Genetics, Inc. Transaction History

Arkadios Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$77.3 - $105.0 $212,033 - $288,015	-2,743 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$74.87 - $110.87 $8,610 - $12,750	115 Added 4.38%	2,743 $246,000
Q2 2021 Jul 28, 2021	BUY	$66.8 - $100.45 $65,263 - $98,139	977 Added 59.18%	2,628 $242,000
Q1 2021 Apr 26, 2021	SELL	$59.3 - $183.85 $15,595 - $48,352	-263 Reduced 13.74%	1,651 $159,000
Q4 2020 Feb 09, 2021	BUY	$31.01 - $52.1 $59,353 - $99,719	1,914 New	1,914 $99,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $554M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.